Skip to main content

Avery Dennison - Fundamentalanalyse - Jahresbericht / Bilanz / Geschäftsbericht

Avery Dennison (ISIN: US0536111091, WKN: 850354) Kursdatum: 21.07.2017 Kurs: 93,890 USD
Beschreibung Daten
Symbol AVY
Marktkapitalisierung 8.722.380.800,00 USD
Land Vereinigte Staaten von Amerika
Indizes S&P 500
Sektor Konsumgüter
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 1996-12-23 - 2:1 |
Internet
Letztes Bilanz Update 23.02.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 21.07.2017
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
25,81 18,41 1,56% 6,63 23,36 31,83 1,46 9,03

Firmenbeschreibung

 

 

NOTE 17. QUARTERLY FINANCIAL INFORMATION (Unaudited)

 

 

      

 

 

 

 

 

(In millions, except per share data)

 

 

 

 

 

 

 

First Quarter

 

 

 

 

 

 

 

Second Quarter

 

 

 

 

 

 

 

Third Quarter

 

 

 

 

 

 

 

Fourth Quarter (1)

 

 

 

 

 

 

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

​  

 

 

 

 

 

 

 

 

2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

 

 

 

 

 

 

$

 

1,528.0

 

 

 

 

 

 

 

$

 

1,516.0

 

 

 

 

 

 

 

$

 

1,468.1

 

 

 

 

 

 

 

$

 

1,454.8

 

 

 

 

 

 

 

 

 

Gross profit

 

 

 

 

 

 

 

 

 

430.0

 

 

 

 

 

 

 

 

 

417.6

 

 

 

 

 

 

 

 

 

405.9

 

 

 

 

 

 

 

 

 

392.3

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

 

 

 

 

 

 

 

 

71.9

 

 

 

 

 

 

 

 

 

64.7

 

 

 

 

 

 

 

 

 

81.3

 

 

 

 

 

 

 

 

 

56.5

 

 

 

 

 

 

 

 

 

(Loss) income from discontinued operations, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1.0

 

 

 

)

 

 

 

 

 

 

 

.4

 

 

 

 

 

 

 

 

 

 

 

.5

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

71.9

 

 

 

 

 

 

 

 

 

63.7

 

 

 

 

 

 

 

 

 

81.7

 

 

 

 

 

 

 

 

 

57.0

 

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

 

 

 

 

 

 

 

 

 

.79

 

 

 

 

 

 

 

 

 

 

 

.71

 

 

 

 

 

 

 

 

 

 

 

.89

 

 

 

 

 

 

 

 

 

 

 

.62

 

 

 

 

 

 

 

 

 

Discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(.01

 

 

 

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

.01

 

 

 

 

 

 

 

 

 

Net income per common share

 

 

 

 

 

 

 

 

 

 

 

.79

 

 

 

 

 

 

 

 

 

 

 

.70

 

 

 

 

 

 

 

 

 

 

 

.89

 

 

 

 

 

 

 

 

 

 

 

.63

 

 

 

 

 

 

 

 

 

Net income (loss) per common share, assuming dilution:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

 

 

 

 

 

 

 

 

 

.78

 

 

 

 

 

 

 

 

 

 

 

.69

 

 

 

 

 

 

 

 

 

 

 

.87

 

 

 

 

 

 

 

 

 

 

 

.61

 

 

 

 

 

 

 

 

 

Discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(.01

 

 

 

)

 

 

 

 

 

 

 

.01

 

 

 

 

 

 

 

 

 

 

 

.01

 

 

 

 

 

 

 

 

 

 

Firmenstrategie

 

 

Principles of Consolidation

 

 

        The consolidated financial statements include the accounts of majority-owned subsidiaries. Intercompany accounts, transactions and profits are eliminated in consolidation.

 

 

RevenueRecognitionPolicyTextBlock

 

 

Revenue Recognition

        Sales are recognized when persuasive evidence of an arrangement exists, pricing is determinable, delivery has occurred based on applicable sales terms, and collection is reasonably assured. Sale terms are free on board (f.o.b.) shipping point or f.o.b. destination, depending upon local business customs. For most regions in which we operate, f.o.b. shipping point terms are utilized and sales are recorded at the time of shipment, because this is when title and risk of loss are transferred. In certain regions, notably in Europe and China, f.o.b. destination terms are generally utilized and sales are recorded when the products are delivered to the customer's delivery site, because this is when title and risk of loss are transferred. Furthermore, sales, provisions for estimated returns, and the cost of products sold are recorded at the time title transfers to customers and when the customers assume the risks and rewards of ownership. Actual product returns are charged against estimated sales return allowances.

        Sales rebates and discounts are common practices in the industries in which we operate. Volume, promotional, price, cash and other discounts and customer incentives are accounted for as a reduction to gross sales. Rebates and discounts are recorded based upon estimates at the time products are sold. These estimates are based on our historical experience for similar programs and products. We review these rebates and discounts on an ongoing basis and accruals for rebates and discounts are adjusted, if necessary, as additional information becomes available.

 

 

SegmentReportingDisclosureTextBlock

 

 

NOTE 15. SEGMENT INFORMATION

Segment Reporting

        We have the following operating and reportable segments:

 

 

 

 
 

 

 
 

 

 
 

           

 
 

          

 
 

Pressure-sensitive Materials – manufactures and sells pressure-sensitive labeling technology and materials, films for graphic and reflective applications, performance polymers (largely adhesives used to manufacture pressure-sensitive materials), and performance tapes;

 
 

           

 
 

          

 
 

Retail Branding and Information Solutions – designs, manufactures and sells a wide variety of branding and information products and services, including brand and price tickets, tags and labels (including RFID inlays), and related services, supplies and equipment; and

 
 

           

 
 

          

 
 

Vancive Medical Technologies – manufactures an array of pressure-sensitive adhesive products for surgical, wound care, ostomy, and electromedical applications.

 

        Intersegment sales are recorded at or near market prices and are eliminated in determining consolidated sales. We evaluate performance based on income from operations before interest expense and taxes. General corporate expenses are also excluded from the computation of income from operations for the segments.

        We do not disclose total assets by reportable segment since we do not produce and review such information internally. As our reporting structure is not organized or reviewed internally by country, results by individual country are not provided.

        Financial information from continuing operations by reportable segment is set forth below:

                                                                                                                                                                                    

 

EarningsPerSharePolicyTextBlock

 

 

NOTE 10. NET INCOME PER COMMON SHARE

        Net income per common share was computed as follows:

                                                                                                                                                                                    

 

 

(In millions)

 
 

 

 
2015 
 

 

 
2014 
 

 

 
2013 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

Net sales to unaffiliated customers

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Pressure-sensitive Materials

 
 

 

 
 

$

 
4,373.7 
 

 

 
 

$

 
4,658.1 
 

 

 
 

$

 
4,455.0 
 

 

 
 

Retail Branding and Information Solutions

 
 

 

 
 

 

 
1,520.3 
 

 

 
 

 

 
1,591.6 
 

 

 
 

 

 
1,611.1 
 

 

 
 

Vancive Medical Technologies

 
 

 

 
 

 

 
72.9 
 

 

 
 

 

 
80.6 
 

 

 
 

 

 
73.9 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

Net sales to unaffiliated customers

 
 

 

 
 

$

 
5,966.9 
 

 

 
 

$

 
6,330.3 
 

 

 
 

$

 
6,140.0 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

Intersegment sales

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Pressure-sensitive Materials

 
 

 

 
 

$

 
60.9 
 

 

 
 

$

 
63.2 
 

 

 
 

$

 
64.6 
 

 

 
 

Retail Branding and Information Solutions

 
 

 

 
 

 

 
1.9 
 

 

 
 

 

 
2.4 
 

 

 
 

 

 
2.4 
 

 

 
 

Vancive Medical Technologies

 
 

 

 
 

 

 
4.9 
 

 

 
 

 

 
9.6 
 

 

 
 

 

 
3.6 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

Intersegment sales

 
 

 

 
 

$

 
67.7 
 

 

 
 

$

 
75.2 
 

 

 
 

$

 
70.6 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

(In millions, except per share amounts)

 
 

 

 
2015 
 

 

 
2014 
 

 

 
2013 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

(A)

 
 

 

 
 

Income from continuing operations

 
 

 

 
 

$

 
274.4 
 

 

 
 

$

 
247.3 
 

 

 
 

$

 
241.7 
 

 

 
 

(B)

 
 

 

 
 

Loss from discontinued operations, net of tax

 
 

 

 
 

 

 
 

(.1

 
 

)

 
 

 

 
(2.2 
 

)

 
 

 

 
(28.5 
 

)

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

(C)

 
 

 

 
 

Net income available to common shareholders

 
 

 

 
 

$

 
274.3 
 

 

 
 

$

 
245.1 
 

 

 
 

$

 
213.2 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

(D)

 
 

 

 
 

Weighted average number of common shares outstanding

 
 

 

 
 

 

 
91.0 
 

 

 
 

 

 
93.8 
 

 

 
 

 

 
98.4 
 

 

 
 

 

 
 

 

 
 

Dilutive shares (additional common shares issuable under stock-based awards)

 
 

 

 
 

 

 
1.9 
 

 

 
 

 

 
1.9 
 

 

 
 

 

 
1.7 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

(E)

 
 

 

 
 

Weighted average number of common shares outstanding, assuming dilution

 
 

 

 
 

 

 
92.9 
 

 

 
 

 

 
95.7 
 

 

 
 

 

 
100.1 
 

 

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

 
 

Net income (loss) per common share:

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

 

 
 

Continuing operations (A) ÷ (D)

 
 

 

 
 

$

 
3.01 
 

 

 
 

$

 
2.64 
 

 

 
 

$

 
2.46 
 

 

 
 

Discontinued operations (B) ÷ (D)

 
 

 

 
 

 

 
 

 
 

 

 
 

 

 
 

(.03

 
 

)

 
 

 

 
 

(.29

 
 

)

 
 

​  

 
 

​  

 
 

​  

 
 

​  

 
 

​